Literature DB >> 28495141

Association of lower serum Brain-derived neurotrophic factor levels with larger infarct volumes in acute ischemic stroke.

Hui-Jie Qiao1, Zhen-Zhi Li1, Li-Ming Wang1, Wei Sun1, Jin-Chao Yu1, Bin Wang2.   

Abstract

OBJECTIVE: Brain-derived neurotrophic factor (BDNF) plays a potential role in stroke recovery, as it promotes plasticity. The aim of this study is to investigate the association between infarct volume using DWI and BDNF at admission in patients with acute ischemic stroke (AIS).
METHODS: The study population comprised consecutive patients with an AIS diagnosis who had been referred to our hospital between January 2015 and June 2016. The severity of stroke was evaluated by the National Institutes of Health Stroke Scale (NIHSS) at admission. Infarct volumes indicated by DWI were measured with MIPAV software. The relationship between median DWI infarct volume and serum BDNF level quartiles was evaluated using a semiparametric approach with univariate and multivariate quartile regression analysis.
RESULTS: In this study, 270 patients were included and met the study criteria. The median DWI infarct volumes for the serum BDNF level quartiles (lowest to highest) were 10.56, 5.13, 3.75 and 2.43ml. Nonparametric Spearman rank correlation revealed a statistically significant negative correlation between serum BDNF level and DWI infarct volume (r=-0.363; P<0.001). The median DWI infarct volume in the lowest BDNF quartile was significantly larger than those in the upper 3 quartiles (P<0.001). Further, median adjusted DWI infarct volumes (IQR) for each of the BDNF level quartiles were 7.77, 4.56, 3.75, and 2.43ml from lowest to highest quartiles.
CONCLUSIONS: Larger stroke infarct volumes using DWI are associated with lower levels of BDNF at admission. Further investigations are suggested to elucidate the role of BDNF as part of a potential neuroprotective strategy.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomarker; Brain-derived neurotrophic factor; Infarct volume; Ischemic stroke

Mesh:

Substances:

Year:  2017        PMID: 28495141     DOI: 10.1016/j.jneuroim.2017.04.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  11 in total

1.  Vildagliptin, a DPP4 inhibitor, alleviates diabetes-associated cognitive deficits by decreasing the levels of apoptosis-related proteins in the rat hippocampus.

Authors:  Dan-Dan Zhang; Nan Shi; Hui Fang; Liang Ma; Wei-Ping Wu; Ya-Zhong Zhang; Jin-Li Tian; Luo-Bing Tian; Kang Kang; Si Chen
Journal:  Exp Ther Med       Date:  2018-04-02       Impact factor: 2.447

2.  Circulating brain-derived neurotrophic factor as a potential biomarker in stroke: a systematic review and meta-analysis.

Authors:  Helia Mojtabavi; Zoha Shaka; Sara Momtazmanesh; Atra Ajdari; Nima Rezaei
Journal:  J Transl Med       Date:  2022-03-14       Impact factor: 5.531

3.  Post-stroke BDNF concentration changes following proprioceptive neuromuscular facilitation (PNF) exercises.

Authors:  Poonam Chaturvedi; Ajai Kumar Singh; Vandana Tiwari; Anup Kumar Thacker
Journal:  J Family Med Prim Care       Date:  2020-07-30

Review 4.  Neurovascular Unit as a Source of Ischemic Stroke Biomarkers-Limitations of Experimental Studies and Perspectives for Clinical Application.

Authors:  Aleksandra Steliga; Przemysław Kowiański; Ewelina Czuba; Monika Waśkow; Janusz Moryś; Grażyna Lietzau
Journal:  Transl Stroke Res       Date:  2019-11-07       Impact factor: 6.800

5.  Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study.

Authors:  Tomás Sobrino; Manuel Rodríguez-Yáñez; Francisco Campos; Ramón Iglesias-Rey; Mónica Millán; Natalia Pérez de la Ossa; Antonio Dávalos; Raquel Delgado-Mederos; Alejandro Martínez-Domeño; Joan Martí-Fábregas; Mar Castellanos; Joaquín Serena; Aida Lago; Exuperio Díez-Tejedor; José Castillo
Journal:  Transl Stroke Res       Date:  2019-11-25       Impact factor: 6.829

6.  Serum BDNF Levels Are Reduced in Patients with Disorders of Consciousness and Are Not Modified by Verticalization with Robot-Assisted Lower-Limb Training.

Authors:  Sergio Bagnato; Giuseppe Galardi; Francesco Ribaudo; Cristina Boccagni; Teresa Valentina Fiorilla; Francesca Rubino; Maria Enza D'Ippolito; Maria Andriolo
Journal:  Neural Plast       Date:  2020-05-22       Impact factor: 3.599

7.  Increase in Blood Levels of Growth Factors Involved in the Neuroplasticity Process by Using an Extremely Low Frequency Electromagnetic Field in Post-stroke Patients.

Authors:  Natalia Cichoń; Michał Bijak; Piotr Czarny; Elżbieta Miller; Ewelina Synowiec; Tomasz Sliwinski; Joanna Saluk-Bijak
Journal:  Front Aging Neurosci       Date:  2018-09-26       Impact factor: 5.750

Review 8.  Targeting phosphodiesterase 4 as a potential therapeutic strategy for enhancing neuroplasticity following ischemic stroke.

Authors:  Haitao Wang; Uma Gaur; Jiao Xiao; Bingtian Xu; Jiangping Xu; Wenhua Zheng
Journal:  Int J Biol Sci       Date:  2018-10-03       Impact factor: 6.580

Review 9.  Microstructure and Genetic Polymorphisms: Role in Motor Rehabilitation After Subcortical Stroke.

Authors:  Jingchun Liu; Caihong Wang
Journal:  Front Aging Neurosci       Date:  2022-02-01       Impact factor: 5.750

Review 10.  Serum BDNF Levels in Acute Stroke: A Systematic Review and Meta-Analysis.

Authors:  Eleni Karantali; Dimitrios Kazis; Vasileios Papavasileiou; Angeliki Prevezianou; Symela Chatzikonstantinou; Foivos Petridis; Jack McKenna; Alina-Costina Luca; Constantin Trus; Alin Ciobica; Ioannis Mavroudis
Journal:  Medicina (Kaunas)       Date:  2021-03-22       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.